Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human 20S Proteasome Y (aa 41-58), Synthetic Peptide, Invitrogen™

Synthetic Peptide

Manufacturer:  Invitrogen PEP173

Catalog No. PEP173

This item has been discontinued by the manufacturer and is no longer available. Please call customer service for assistance: 1-800-766-7000.


Description

Description

Human 20S Proteasome Y (residues 41-58) Synthetic Peptide, PEP-173, from Invitrogen.

PEP-173 is an 18 amino acid synthetic peptide whose sequence is derived from human proteasome 20S Y and amino acid residues 74-91 from frog protein. The sequence of this peptide is (amino to carboxy terminus): C (41)-R-S-G-S-A-A-D-T-Q-A-V /I-A-D-A-V-T-Y (58)This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human proteasome 20S Y, catalog # PA1-978. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.
Specifications

Specifications

Synthetic Peptide
5694
Human
0.5 mg/mL
Lyophilized
Y
RUO
No preservative
PSMB6
Control
Human
purified
50μg
Control
peptide with no preservative
C(41)-R-S-G-S-A-A-D-T-Q-A-V /I-A-D-A-V-T-Y(58)
-20° C, Avoid Freeze/Thaw Cycles
Human 20S Proteasome Y (aa 41-58)
P28072
Peptide
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit